AB
RVMD icon

Amalgamated Bank’s Revolution Medicines RVMD Stock Holding History

Amalgamated Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Buy
13,867
+5,608
+68% +$819K 0.02% 710
2026
Q1 		$803K Sell
8,259
-180
-2% -$18.2K 0.01% 1158
2025
Q4 		$672K Sell
8,439
-251
-3% -$16.5K ﹤0.01% 1214
2025
Q3 		$406K Sell
8,690
-90
-1% -$3.52K ﹤0.01% 1385
2025
Q2 		$323K Buy
8,780
+2,910
+50% +$112K ﹤0.01% 1424
2025
Q1 		$208K Buy
5,870
+163
+3% +$6.62K ﹤0.01% 1527
2024
Q4 		$250K Buy
5,707
+435
+8% +$22K ﹤0.01% 1521
2024
Q3 		$239K Hold
5,272
– – ﹤0.01% 1531
2024
Q2 		$205K Buy
5,272
+365
+7% +$13.6K ﹤0.01% 1573
2024
Q1 		$158K Sell
4,907
-13,588
-73% -$403K ﹤0.01% 1650
2023
Q4 		$530K Buy
18,495
+2,908
+19% +$69.9K ﹤0.01% 1424
2023
Q3 		$431K Buy
15,587
+787
+5% +$23.3K ﹤0.01% 1482
2023
Q2 		$396K Buy
14,800
+5,151
+53% +$126K ﹤0.01% 1550
2023
Q1 		$209K Sell
9,649
-497
-5% -$12.2K ﹤0.01% 1785
2022
Q4 		$242K Buy
10,146
+181
+2% +$3.85K ﹤0.01% 1783
2022
Q3 		$197K Buy
9,965
+1,673
+20% +$36.8K ﹤0.01% 1859
2022
Q2 		$162K Buy
8,292
+770
+10% +$15K ﹤0.01% 1966
2022
Q1 		$192K Sell
7,522
-566
-7% -$12.3K ﹤0.01% 1953
2021
Q4 		$204K Sell
8,088
-99
-1% -$2.79K ﹤0.01% 1969
2021
Q3 		$225K Sell
8,187
-561
-6% -$16.3K ﹤0.01% 1952
2021
Q2 		$278K Buy
8,748
+2,673
+44% +$93.3K ﹤0.01% 1922
2021
Q1 		$279K Buy
6,075
+44
+0.7% +$1.97K 0.01% 1308
2020
Q4 		$239K Buy
6,031
+33
+0.6% +$1.3K 0.01% 1353
2020
Q3 		$209K Buy
+5,998
New +$166K 0.01% 1305

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Amalgamated Bank's RVMD Position: Q2 2026 in Review

Amalgamated Bank increased its Revolution Medicines (RVMD) stake by 68% in Q2 2026, buying an estimated $819K and bringing the position to 13,867 shares worth $2.6M. The position accounts for 0.02% of the portfolio, ranked #710.

Amalgamated Bank first reported a position in RVMD in Q3 2020 and has held it in 24 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Amalgamated Bank held 13,867 shares of Revolution Medicines worth $2.6M as of Q2 2026.
  • Amalgamated Bank bought 5,608 Revolution Medicines shares in Q2 2026, an estimated $819K.
  • Revolution Medicines made up 0.02% of Amalgamated Bank's portfolio in Q2 2026, its #710 holding.
  • Amalgamated Bank first reported a position in Revolution Medicines in Q3 2020 and has held it in 24 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.